Accordingly, sHER2 release in the culture supernatant was proportional to cell growth in the absence of T-DM1, but became proportional to cell death in T-DM1-treated breast cancer cells, with an apparent relocation of HER2 from the intracellular compartment into the culture supernatant (Fig. 4). This evidence concerns the gene ERBB2 and breast carcinoma.